Announcements Trials
Browse Landscape

Phase

Phase 4 5Phase 2 1

Status

Recruiting 2Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

pembrolizumab 196Nivolumab 145Carboplatin 134Specimen Handling 130Magnetic Resonance Spectroscopy 115Cyclophosphamide 109Paclitaxel 106Cisplatin 98Biopsy 97Radiotherapy 90durvalumab 81Dexamethasone 79atezolizumab 73Ipilimumab 62Gemcitabine 62Rituximab 59Doxorubicin 59Lenalidomide 55Docetaxel 55olaparib 53Bevacizumab 51Capecitabine 50Fluorouracil 49Etoposide 49Radiation 47Oxaliplatin 47Radiosurgery 43venetoclax 42Prednisone 42Taxes 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Active not recruiting × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT03036930 2026-05-29

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

National Cancer Institute (NCI)

Phase 2 Active not recruiting
51 enrolled 10 charts

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡